Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin

International Journal of Cardiology

Volumn 147, Issue 1, 2011, Pages 95-111

  Wiese, Cornelia ^a,d   Nikolova, Teodora ^a,e   Zahanich, Ihor ^b,c   Sulzbacher, Sabine ^a   Fuchs, Joerg ^a   Yamanaka, Satoshi ^b   Graf, Eva ^c   Ravens, Ursula ^c   Boheler, Kenneth R ^b   Wobus, Anna M ^a  

^a LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Brachyury; Cardiac differentiation; Embryonic stem cells; Mouse; Sinus node like cells; Suramin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CELL MARKER; FIBROBLAST GROWTH FACTOR 10; SURAMIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 5; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX5; WNT11 PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHYSIOLOGY; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDODERM; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART ATRIUM; HEART MUSCLE CELL; HEART VENTRICLE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MESODERM; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUS NODE; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; MICE; MYOCYTES, CARDIAC; SINOATRIAL NODE; SURAMIN;

EID: 79951727653     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.08.021     Document Type: Article

References (84)

1. Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV, Wobus AM. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002;91:189-201. (Pubitemid 34875673)
2. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-83. (Pubitemid 40322227)
3. Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005;85:635-78. (Pubitemid 40404638)
4. van Laake L, Hassink R, Doevendans P, Mummery C. Heart repair and stem cells. J Physiol 2006;577:467-78. (Pubitemid 44804006)
5. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 1993;44:41-50. (Pubitemid 24037697)
6. Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 1994;75:233-44. (Pubitemid 24228315)
7. 2+ current in the early stages of cardiomyocyte development. Circ Res 1999;84:136-45.
8. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-14. (Pubitemid 32730787)
9. Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J, Gepstein L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 2002;91: 659-61. (Pubitemid 35204947)
10. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003;93:32-9. (Pubitemid 36859038)
11. Reppel M, Pillekamp F, Brockmeier K, et al. The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J Electrocardiol 2005;38:166-70. (Pubitemid 41436507)
12. Fijnvandraat AC, van Ginneken AC, de Boer PA, et al. Cardiomyocytes derived from embryonic stem cells resemble cardiomyocytes of the embryonic heart tube. Cardiovasc Res 2003;58:399-409. (Pubitemid 36570398)
13. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996;98:216-24. (Pubitemid 26243839)
14. Metzger JM, Lin WI, Samuelson LC. Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. Circ Res 1996;78:547-52. (Pubitemid 26106869)
15. Wobus AM, Kaomei G, Shan J, et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997;29:1525-39. (Pubitemid 27270224)
16. Kolossov E, Fleischmann BK, Liu Q, et al. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 1998;143:2045-56. (Pubitemid 29022623)
17. Meyer N, Jaconi M, Landopoulou A, Fort P, Puceat M. A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 2000;478:151-8. (Pubitemid 30462277)
18. Muller M, Fleischmann BK, Selbert S, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000;14:2540-8.
19. Lough J, Barron M, Brogley M, Sugi Y, Bolender DL, Zhu X. Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev Biol 1996;178:198-202. (Pubitemid 26297253)
20. Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 1997;11:451-62. (Pubitemid 27097644)
21. Barron M, Gao M, Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 2000;218:383-93. (Pubitemid 30349647)
22. Pandur P, Lasche M, Eisenberg LM, Kuhl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002;418:636-41.
23. Nakamura T, Sano M, Songyang Z, Schneider MD. A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 2003;100:5834-9. (Pubitemid 36576894)
24. Wollert KC, Chien KR. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med 1997;75:492-501. (Pubitemid 27314956)
25. Gourdie RG, Wei Y, Kim D, Klatt SC, Mikawa T. Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers. Proc Natl Acad Sci U S A 1998;95:6815-8. (Pubitemid 28278063)
26. Rentschler S, Zander J, Meyers K, et al. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci U S A 2002;99:10464-9.
27. Urbinati C, Chiodelli P, Rusnati M. Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis. Molecules 2008;13:2758-85.
28. Bono F, Rigon P, Lamarche I, Savi P, Salel V, Herbert JM. Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells. Biochem J 1997;326(Pt 3):661-8. (Pubitemid 27438037)
29. Kathir KM, Kumar TK, Yu C. Understanding the mechanism of the antimitogenic activity of suramin. Biochemistry 2006;45:899-906. (Pubitemid 43122254)
30. Betsholtz C, Johnsson A, Heldin CH, Westermark B. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci U S A 1986;83:6440-4. (Pubitemid 17174750)
31. Pollak M, Richard M. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells. J Natl Cancer Inst 1990;82:1349-52.
32. Williams LT, Tremble PM, Lavin MF, Sunday ME. Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. J Biol Chem 1984;259:5287-94. (Pubitemid 14140639)
33. Coffey Jr RJ, Leof EB, Shipley GD, Moses HL. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 1987;132:143-8. (Pubitemid 17105335)
34. Smolich BD, McMahon JA, McMahon AP, Papkoff J. Wnt family proteins are secreted and associated with the cell surface. Mol Biol Cell 1993;4:1267-75. (Pubitemid 24045757)
35. Strassmann G, D'Alessandro F, Fong M, Nordan RP, Nickel P, Chizzonite R. Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities. Int J Immunopharmacol 1994;16:931-9. (Pubitemid 24341673)
36. Mills GB, Zhang N, May C, Hill M, Chung A. Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression. Cancer Res 1990;50:3036-42. (Pubitemid 20170759)
37. Leland P, Obiri N, Aggarwal BB, Puri RK. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. Oncol Res 1995;7:227-35.
38. Alzani R, Corti A, Grazioli L, Cozzi E, Ghezzi P, Marcucci F. Suramin induces deoligomerization of human tumor necrosis factor alpha. J Biol Chem 1993;268:12526-9. (Pubitemid 23182411)
39. Hensey CE, Boscoboinik D, Azzi A. Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A. FEBS Lett 1989;258:156-8. (Pubitemid 19283746)
40. Mahoney CW, Azzi A, Huang KP. Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes. J Biol Chem 1990;265:5424-8.
41. Kopp R, Pfeiffer A. Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells. Cancer Res 1990;50:6490-6. (Pubitemid 20348766)
42. Zhang YL, Keng YF, Zhao Y, Wu L, Zhang ZY. Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases. J Biol Chem 1998;273:12281-7. (Pubitemid 28240595)
43. Beindl W, Mitterauer T, Hohenegger M, Ijzerman AP, Nanoff C, Freissmuth M. Inhibition of receptor/G protein coupling by suramin analogues. Mol Pharmacol 1996;50:415-23. (Pubitemid 26265148)
44. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004;22:1282-9. (Pubitemid 39341201)
45. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005;111:11-20. (Pubitemid 40070838)
46. Wobus AM, Guan K, Yang HT, Boheler KR. Embryonic stem cells as a model to study cardiac, skeletal muscle, and vascular smooth muscle cell differentiation. Methods Mol Biol 2002;185:127-56.
47. Mountford P, Zevnik B, Duwel A, et al. Dicistronic targeting constructs: reporters and modifiers ofmammalian gene expression. Proc Natl Acad Sci U S A 1994;91: 4303-7. (Pubitemid 24143421)
48. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162: 156-9. (Pubitemid 17064313)
49. Christ T, Wettwer E, Dobrev D, et al. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 2001;33:1515-25. (Pubitemid 32681669)
50. Yang HT, Tweedie D, Wang S, et al. The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A 2002;99:9225-30. (Pubitemid 34764595)
51. Ajioka I, Maeda T, Nakajima K. Identification of ventricular-side- enriched molecules regulated in a stage-dependent manner during cerebral cortical development. Eur J Neurosci 2006;23:296-308.
52. Fassler R, Rohwedel J, Maltsev V, et al. Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin. J Cell Sci 1996;109(Pt 13): 2989-99. (Pubitemid 27029269)
53. Stieber J, Herrmann S, Feil S, et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci U S A 2003;100:15235-40. (Pubitemid 37518045)
54. Hoogaars WM, Tessari A, Moorman AF, et al. The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart. Cardiovasc Res 2004;62:489-99. (Pubitemid 38648963)
55. Hoogaars WM, Engel A, Brons JF, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev 2007;21: 1098-112. (Pubitemid 46686478)
56. Christoffels VM, Hoogaars WM, Tessari A, Clout DE, Moorman AF, Campione M. T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers. Dev Dyn 2004;229:763-70.
57. Kreuzberg MM, Sohl G, Kim JS, Verselis VK, Willecke K, Bukauskas FF. Functional properties of mouse connexin30.2 expressed in the conduction system of the heart. Circ Res 2005;96:1169-77. (Pubitemid 40827692)
58. Delorme B, Dahl E, Jarry-Guichard T, et al. Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. Circ Res 1997;81:423-37. (Pubitemid 27362530)
59. Habib M, Caspi O, Gepstein L. Human embryonic stem cells for cardiomyogenesis. J Mol Cell Cardiol 2008;45:462-74.
60. Perino MG, Yamanaka S, Li J, Wobus AM, Boheler KR. Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol 2008;45:475-94.
61. Marban E, Cho HC. Creation of a biological pacemaker by gene- or cell-based approaches. Med Biol Eng Comput 2007;45:133-44. (Pubitemid 46291439)
62. Grunz H. Suramin changes the fate of Spemann's organizer and prevents neural induction in Xenopus laevis. Mech Dev 1992;38:133-41.
63. Grunz H. Amphibian embryos as a model system for organ engineering: in vitro induction and rescue of the heart anlage. Int J Dev Biol 1999;43:361-4. (Pubitemid 29362898)
64. Oschwald R, Clement JH, Knochel W, Grunz H. Suramin prevents transcription of dorsal marker genes in Xenopus laevis embryos, isolated dorsal blastopore lips and activin A induced animal caps. Mech Dev 1993;43:121-33. (Pubitemid 23352037)
65. Fainsod A, Steinbeisser H, De Robertis EM. On the function of BMP-4 in patterning the marginal zone of the Xenopus embryo. EMBO J 1994;13:5015-25. (Pubitemid 24341082)
66. Liu Y, Asakura M, Inoue H, et al. Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc Natl Acad Sci U S A 2007;104:3859-64. (Pubitemid 47181544)
67. Eisenberg CA, Eisenberg LM. WNT11 promotes cardiac tissue formation of early mesoderm. Dev Dyn 1999;216:45-58. (Pubitemid 29416172)
68. Terami H, Hidaka K, Katsumata T, Iio A, Morisaki T. Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes. Biochem Biophys Res Commun 2004;325:968-75. (Pubitemid 39487966)
69. Jaspard B, Couffinhal T, Dufourcq P, Moreau C, Duplaa C. Expression pattern ofmouse sFRP-1 and mWnt-8 gene during heart morphogenesis. Mech Dev 2000;90:263-7. (Pubitemid 30042931)
70. Lie DC, Colamarino SA, Song HJ, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005;437:1370-5. (Pubitemid 41568684)
71. Baker JC, Beddington RS, Harland RM. Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development. Genes Dev 1999;13: 3149-59.
72. Yamaguchi TP, Takada S, Yoshikawa Y, Wu N, McMahon AP. T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes Dev 1999;13: 3185-90. (Pubitemid 30030440)
73. Ohuchi H, Noji S. Fibroblast-growth-factor-induced additional limbs in the study of initiation of limb formation, limb identity, myogenesis, and innervation. Cell Tissue Res 1999;296:45-56. (Pubitemid 29179371)
74. Kouskoff V, Lacaud G, Schwantz S, Fehling HJ, Keller G. Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A 2005;102:13170-5. (Pubitemid 41324997)
75. van Wijk B, Moorman AF, van den Hoff MJ. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 2006;74:244-55.
76. Yuasa S, Itabashi Y, Koshimizu U, et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 2005;23:607-11. (Pubitemid 41724900)
77. van Kempen MJ, Vermeulen JL, Moorman AF, Gros D, Paul DL, Lamers WH. Developmental changes of connexin40 and connexin43 mRNA distribution patterns in the rat heart. Cardiovasc Res 1996;32:886-900.
78. Miquerol L, Dupays L, Theveniau-Ruissy M, et al. Gap junctional connexins in the developing mouse cardiac conduction system.Novartis Found Symp 2003;250: 80-98.
79. Marionneau C, Couette B, Liu J, et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 2005;562: 223-34. (Pubitemid 40207799)
80. Habets PE, Moorman AF, Clout DE, et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev 2002;16:1234-46.
81. Yang L, Cai CL, Lin L, et al. Isl1Cre reveals a common Bmp pathway in heart and limb development. Development 2006;133:1575-85. (Pubitemid 43732970)
82. Mommersteeg MT, Hoogaars WM, Prall OW, et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 2007;100:354-62.
83. Liberatore CM, Searcy-Schrick RD, Vincent EB, Yutzey KE. Nkx-2.5 gene induction in mice ismediated by a Smad consensus regulatory region.Dev Biol 2002;244: 243-56.
84. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.